Miraluma Test

What the Miraluma Test Means

The Miraluma Test is a special breast imaging procedure also known as scintimammography or sestamibi breast imaging. It is designed to help find cancer cells in the breast by using a small injection of a radioactive substance called technetium 99. This substance tends to collect in cancer cells more than in normal tissue. After the injection, a gamma camera takes pictures of the breasts to show areas where cancer cells might be present. This test is different from a mammogram, which uses X-rays to create images of breast tissue.

Why the Miraluma Test Can Matter in Cancer Care

This test can be helpful for women who have had unclear or abnormal mammogram results, especially if they have dense breast tissue, scar tissue from surgery, or breast implants. Dense breast tissue can make it harder for mammograms to detect cancer clearly. The Miraluma Test can sometimes find cancers that mammograms miss. However, it is not used for routine breast cancer screening because it involves exposure to radiation and may not detect all types of breast changes. It is usually used as an additional tool when doctors need more information.

What Patients Might Experience or See

If your care team recommends the Miraluma Test, you will receive an injection of a small amount of radioactive material. The injection is generally safe and the amount of radiation is low, but it is more than a standard mammogram. You will then lie still while a special camera takes pictures of your breasts. The test usually takes longer than a mammogram. You might see the test called by different names, such as scintimammography or sestamibi breast imaging, in your medical records or reports.

How to Understand the Test Results and Its Limits

It is important to know that not all areas that absorb the radioactive substance are cancer. Some benign (non-cancerous) conditions, like fibroadenomas, can also show up on the test. Because of this, doctors use the Miraluma Test carefully and usually alongside other tests and exams. A positive result does not automatically mean cancer, and a negative result does not guarantee there is no cancer. Always discuss what your specific results mean with your care team.

Common Confusions and Questions to Ask

The Miraluma Test may be called by several names, which can be confusing. If you see terms like scintimammography or sestamibi breast imaging, they refer to the same test. If the test is mentioned in your medical records or during your care, ask your doctor or nurse how it applies to your situation. Questions you might ask include why this test is recommended, how it differs from a mammogram, what the risks are, and what the results might mean for your care plan.

Reading the Term in Context and Next Steps

Seeing the term Miraluma Test in a report or discussion does not mean you have cancer or that a certain treatment is planned. It is one piece of information that helps doctors understand breast health better. This entry is for education and cannot decide what is right for you. The best next step if you encounter this term is to talk with your care team about what the test means for your diagnosis, treatment, or follow-up. They can explain how it fits into your overall care and what to expect.